首页 | 本学科首页   官方微博 | 高级检索  
     

术前化疗结合放疗治疗炎性乳腺癌疗效分析
引用本文:任洪波,王琦,李少林,黄碧有. 术前化疗结合放疗治疗炎性乳腺癌疗效分析[J]. 中国肿瘤临床, 2006, 33(7): 384-385
作者姓名:任洪波  王琦  李少林  黄碧有
作者单位:1. 重庆市巴南区第二人民医院肿瘤科,重庆市,400054
2. 重庆医科大学
摘    要:目的:探讨术前化疗结合放疗治疗炎性乳腺癌的疗效。方法:采用环磷酰胺(CTX),吡柔比星(THP—ADM),氟脲嘧啶(5-FU)或CTX、甲氨喋呤(MTX)、5-FU化疗治疗21例炎性乳腺癌,每21天重复治疗。结果:全部病例随访5年以上.随访率100%。总有效率85.7%,3年、5年生存率为42.9%、23.8%。结论:炎性乳腺癌预后差,经术前化疗、放疗结合局部治疗可取得较好疗效。

关 键 词:炎性乳腺癌  化学治疗  放射治疗  手术治疗
文章编号:1000-8179(2006)07-0384-02
收稿时间:2005-08-01
修稿时间:2005-08-012006-01-20

The Analysis of Curative Effect for Preoperative Chemoradiotherapy on Inflammatory Breast Cancer
Ren Hongbo, Wang Qi, Li Shaolin et al. The Analysis of Curative Effect for Preoperative Chemoradiotherapy on Inflammatory Breast Cancer[J]. Chinese Journal of Clinical Oncology, 2006, 33(7): 384-385
Authors:Ren Hongbo   Wang Qi   Li Shaolin et al
Abstract:Objective: To observe the effect of preoperative chemo-radiotherapy for inflammatory breast cancer. Methods: Twenty-one patients with inflammatory breast carcinoma were treated with a combined-modality approach. The protocol included chemotherapy consisted of cyclophosphamide, pirarubicin and 5-fluorouracil or cyclophosphamide, amothopterm and 5-fluorouracil. The same infusion schedule was repeated on day 21, total 3~4 cycles, then radiotherapy. Results: All patients were followed up at more than 5 years. The follow-up rate was 100.00%. The 3-year and 5-year survival rate were 42.9% and 23.8% respectively. Conclusion: Use of combined-modality treatment is recommended as a standard of care for inflammatory breast carcinoma.
Keywords:Inflammatory breast carcinoma Chemotherapy Radiotherapy Surgery
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号